(Q40401092)

20 September 2017

title

Demonstration of the herd effect in adults after the implementation of pneumococcal vaccination with PCV13 in children (English)

1 reference

20 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Claire Poyart

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Q Vermee

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

A Agathine

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

A Dupuis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

E Varon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

M-C Ploy

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

J Raymond

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

and the ORP Ile de France Ouest

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

publication date

20 December 2016

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

20 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

831-838

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28000028%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10096-016-2868-5

8 June 2020

exact match

0 references

cites work

Streptococcus pneumoniae colonisation: the key to pneumococcal disease

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

From ecological reservoir to disease: the nasopharynx, day-care centres and drug-resistant clones of Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Emergence of Streptococcus pneumoniae of serotype 19A in France: molecular capsular serotyping, antimicrobial susceptibilities, and epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Evidence of a clonal expansion of Streptococcus pneumoniae serotype 19A in adults as in children assessed by the DiversiLab® system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Heptavalent pneumococcal conjugate vaccine: current and future impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Early impact of PCV7/PCV13 sequential introduction to the national pediatric immunization plan, on adult invasive pneumococcal disease: A nationwide surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Insight Into Resistance Phenotypes of Emergent Non 13-valent Pneumococcal Conjugate Vaccine Type Pneumococci Isolated From Invasive Disease After 13-valent Pneumococcal Conjugate Vaccine Implementation in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Changes in childhood pneumonia and infant mortality rates following introduction of the 13-valent pneumococcal conjugate vaccine in Nicaragua

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Early trends in invasive pneumococcal disease in children following the introduction of 13-valent pneumococcal conjugate vaccine: results from eight years of active surveillance in a Mexican hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Effect of pneumococcal conjugate vaccination in Uruguay, a middle-income country

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Decline in antibiotic resistance and changes in the serotype distribution of Streptococcus pneumoniae isolates from children with acute otitis media; a 2001-2011 survey by the French Pneumococcal Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Declining mortality from adult pneumococcal infections linked to children's vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Pneumococcal serotype evolution in Western Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Serotype 3 Remains the Leading Cause of Invasive Pneumococcal Disease in Adults in Portugal (2012-2014) Despite Continued Reductions in Other 13-Valent Conjugate Vaccine Serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-016-2868-5

Epidemiological differences among pneumococcal serotypes

21 January 2018

1 reference

12 December 2020

Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.

1 reference

12 December 2020

Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults

1 reference

12 December 2020

Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine

1 reference

12 December 2020

Herd immunity and pneumococcal conjugate vaccine: a quantitative model

1 reference

12 December 2020